<DOC>
	<DOC>NCT02947620</DOC>
	<brief_summary>A Multi-center, Randomized, double-blind, active-controlled, phase 3 trial to evaluate the safety and efficacy of Metformin/Atorvastatin in subjects with Type II Diabetes and dyslipidemia.</brief_summary>
	<brief_title>A Multi-center, Randomized, Double-blind, Active-controlled, Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Subjects with Dyslipidemia and Type II Diabetes 19 years later, men and women under the age of 80 Pregnant women, nursing mothers or subject who does not agree to assigned contraception in the study Subject with type I Diabetes Subject with hypertension which does not controlled by treatment(have blood pressure &gt; 180/110mmHg)</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>